RIPE-KG · Version 1.1.0 · Resource
ripekg:publication-details/RIPEAD590A93EC19D8A75
https://w3id.org/ripe/ripe-kg/publication-details/RIPEAD590A93EC19D8A75
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEAD590A93EC19D8A75 |
prov:used |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prism:eIssn |
1099-1573 |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prism:endingPage |
2964 |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prism:issn |
0951-418X |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prism:publicationDate |
2023-03-02 |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prism:publicationName |
Phytotherapy Research |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prism:startingPage |
2957 |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
dcterms:publisher |
ripekg:publisher/RIPEP932ECA8E36309A4DWiley |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
dcterms:title |
The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
rdf:type |
http://purl.org/spar/fabio/BibliographicMetadata |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
rdf:type |
rdfs:Resource |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
rdf:type |
owl:Thing |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
rdf:type |
ripe:PublicationDetailsPublication details |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
rdf:type |
tido:Evidence |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAD590A93EC19D8A75 |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAD590A93EC19D8A75 |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
ripe:concerns |
ripekg:work/10.1002%2Fptr.7791The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
ripe:concerns |
ripekg:work/10.1002%2Fptr.7791In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAD590A93EC19D8A75-human-1-1 |
ripekg:publication-details/RIPEAD590A93EC19D8A75The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double‐blind, controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAD590A93EC19D8A75-inspectai-1-1 |